Monday, August 31, 2020

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion The offer values the California-based biopharmaceutical company at $2.6 billion, including the $473 million that Nestle had already invested in Aimmune, Nestle said in a statement.

from Moneycontrol Business News https://ift.tt/2QEFiGF

No comments:

Post a Comment

Vikas Khemani on key triggers that will shape the market’s next big move

Most people kind of turned bearish on global concerns, oil prices. So, people tend to kind of extrapolate more bad news. So that has happene...